Canaccord have upgraded their recommendation on DNA to a buy this morning with a $1.04 price target. They've upped their EPS forecasts by 10% in FY14 and by a whopping 72% in FY15.
We are currently only trading at about 12X their FY15 target, which seems good value to me.
Canaccord have upgraded their recommendation on DNA to a buy...
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.009(23.1%) |
Mkt cap ! $37.06M | |||
| Open | High | Low | Value | Volume |
| 3.5¢ | 3.5¢ | 2.9¢ | $97.72K | 3.110M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 517096 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 112500 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| DNA (ASX) Chart |